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Background: Ginsenoside Rd (GSRd), a main component of the root of Panax ginseng, exhibits anti-
inﬂammation functions and decreases infarct size in many injuries and ischemia diseases such as focal
cerebral ischemia. M1 Macrophages are regarded as one of the key inﬂammatory cells having functions
for disease progression.
Methods: To investigate the effect of GSRd on renal ischemia/reperfusion injury (IRI) and macrophage
functional status, and their regulatory role on mouse polarized macrophages in vitro, GSRd (10e100 mg/
kg) and vehicle were applied to mice 30 min before renal IRI modeling. Renal functions were reﬂected by
blood serum creatinine and blood urea nitrogen level and histopathological examination. M1 polarized
macrophages inﬁltration was identiﬁed by ﬂow cytometry analysis and immunoﬂuorescence staining
with CD11bþ, iNOSþ/interleukin-12/tumor necrosis factor-a labeling. For the in vitro study, GSRd (10
e100 mg/mL) and vehicle were added in the culture medium of M1 macrophages to assess their regu-
latory function on polarization phenotype.
Results: In vivo data showed a protective role of GSRd at 50 mg/kg on Day 3. Serum level of serum
creatinine and blood urea nitrogen signiﬁcantly dropped compared with other groups. Reduced renal
tissue damage and M1 macrophage inﬁltration showed on hematoxylineeosin staining and ﬂow
cytometry and immunoﬂuorescence staining conﬁrmed this improvement. With GSRd administration,
in vitro cultured M1 macrophages secreted less inﬂammatory cytokines such as interleukin-12 and tumor
necrosis factor-a. Furthermore, macrophage polarization-related pancake-like morphology gradually
changed along with increasing concentration of GSRd in the medium.
Conclusion: These ﬁndings demonstrate that GSRd possess a protective function against renal ischemia/
reperfusion injury via downregulating M1 macrophage polarization.
Copyright 2015, The Korean Society of Ginseng, Published by Elsevier. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ginseng, the root of Panax ginseng Meyer (Araliaceae), has been
used as medication in Asia for thousands of years. Recent studies
have shown that ginseng saponins (ginsenosides) are the compo-
nents responsible for therapeutic and pharmacologic effects.
Dammar-24(25)-ene-3b,12b,20(S)-triol-(20-O-b-D-glucopyr-
anosyl)-3-O-b-D-glucopyranosyl-(1/2)-b-D-glucopyranoside
(ginsenoside Rd, GSRd, C48H82O18$3H2O) is one of the mainiseases, Tangdu Hospital, The Fou
.
ght 2015, The Korean Society of Gi
d/4.0/).ginsenosides. Studies have shown that GSRd have antitumor and
anti-inﬂammation properties [1,2]. In a rat myocardial ischemia/
reperfusion injury (IRI) model, GSRd reduced myocardial infarct
size, apoptotic cell death, and blood creatine kinase/lactate dehy-
drogenase levels [3]. GSRd has also shown neuroprotection in
transient focal cerebral ischemia, which may involve early free
radical scavenging pathways and late anti-inﬂammatory effects,
and such protection effect appears to have connections with
microglial cells [2].rth Military Medical University, Xi’an, 710038, China.
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delayed graft function, rejection, and renal failure. Potential
molecular and cellular mechanisms have long been investigated for
this pathological damage. Caspase activation, cytochrome C release,
cytosolic calcium overload, and burst of free radicals would cause
cell injury, apoptosis and necrosis [4,5]. Immune cells are also
involved in the process. Neutrophils attracted by chemokines lead
to vascular congestion and cell damage via adhering to endothelial
cells [6] and degranulation [7].
Macrophages are a group of innate immune cells that have
great phagocytosis and secretion capability. Based on their func-
tions, two subgroups of macrophage are deﬁned as classically
activated (M1) and alternatively activated (M2) macrophages [8,9].
M1 macrophages, marked as CD11bþ iNOSþ in mouse, have strong
phagocytic capability for scavenging microorganisms or cell
debris. They can secrete proinﬂammatory cytokines such as
interleukin (IL)-6, IL-12, and tumor necrosis factor (TNF)-a, and
attract more inﬂammatory cells to promote further progress of
inﬂammation. These functions would aggravate cell and tissue
damage [10]. It has been reported that iNOSþ M1 macrophages are
recruited into kidney in the ﬁrst 48 hours after ischemia/reper-
fusion injury. However, predepletion of these macrophages could
reduce renal injury, and depletion at 3e5 days after injury slows
tubular cell proliferation and repair, indicating that M1 macro-
phages exacerbate renal injury [11]. By contrast, M2 macrophages
have lower ability of phagocytosis and proinﬂammatory function.
In some study, these alternatively activated macrophages could
promote renal ﬁbrosis by promoting formation of extracellular
matrix and recruiting ﬁbroblasts [12,13].
Although there are studies that discuss GSRd functions on
ischemia injury [3], and its potential role on M1 macrophages by
in vitro study [14], the role GSRd played on renal IRI and on M1
macrophages in vivo is still unknown. In the present study, we
investigated the therapeutic effect of GSRd on renal IRI and
functional status of macrophages in injured tissue, and further
discuss its regulatory role on in vitro mouse polarized
macrophages.2. Materials and methods
2.1. Renal IRI
This study was performed in adherence with the National
Institutes of Health Guide for the care and use of laboratory
animals, and was approved by the Fourth Military Medical Uni-
versity Committee on animal care. Male C57 BL/6 mice, age 6e8
weeks and weighing 16e18 g, were obtained from the Experi-
mental Animal Center of Fourth Military Medical University
(Xi’an, China). In brief, mice were anesthetized with ketamine
(100 mg/kg intraperitoneally) and xylazine (10 mg/kg intraperi-
toneally). Bilateral renal pedicles were clamped for 25 min with
nontraumatic microaneurysm clamps. After removing the clamp
and suturing the incision, mice were kept on a heating pad to
maintain constant body temperature at 37C and received anal-
gesia. The control sham group was only given anesthesia and
laparotomy. On Days 1, 3, 5, and 7 postsurgery, kidneys were
obtained in each group at the scheduled end points, and mice
blood was collected as well. GSRd (purity 98%; Tai-He Biophar-
maceutical Co. Ltd, Guangzhou, China) stock solutions were pre-
pared in saline containing 10% 1, 3-propanediol (v/v). GSRd at
10 mg/kg, 20 mg/kg, 50 mg/kg, and 100 mg/kg and vehicle were
applied intraperitoneally 30 min before renal IRI. These groups
are referred to as IRIþ10, IRIþ20, IRIþ50, IRIþ100 and IRIþvehicle
hereinafter.2.2. Renal functions
Mice orbital blood was collected in heparinized tubes when
sacriﬁced. Blood was centrifuged at 14,000 g for 10 min to obtain
plasma. Serum creatinine (Scr) and blood urea nitrogen (BUN) were
analyzed with Scr and BUN assay kit (Nanjing Jiancheng Bioengi-
neering Institute, China) by Roche Hitachi Modular Chemistry
analyzer.
2.3. Histological analysis
Kidney was perfused with cold phosphate-buffered saline and
formalin before harvesting and ﬁxed in formalin for 24 hours and
embedded in parafﬁn follow routine protocol. The samples were
sectioned as 4-mm thick slices for hematoxylineeosin staining.
Tissue sections were examined and scored by light microscopy and
evaluated for peritubular leukocyte inﬁltration, tubular cell
swelling and epithelial necrosis on scale of 0e4 according to the
following: 0: no involvement; 1: <25% involvement; 2: 25e50%
involvement; 3: 50e75% involvement; and 4: >75% involvement.
For immunoﬂuorescence staining, tissues were ﬁxed in 4%
paraformaldehyde for 12 h at 4C, followed by 25% sucrose in
phosphate-buffered saline dehydration overnight. Samples were
embedded in optimal cutting temperature compound (Sakura
Finetek, Inc., Torrance, CA, USA), sectioned at 10-mm thickness, and
then dried at room temperature for 2 h before sectioning. Macro-
phages were stained with Biotin CD11b antibody (ab24954; Abcam,
Cambridge, MA, USA) and ExtrAvidin-Cy3 conjugate (E4142;
SigmaeAldrich, St Louis, MO, USA); M1 phenotype was marked
by anti-iNOS antibody (ab15323; Abcam), anti-IL12 antibody
(ab203031; Abcam), anti-TNFa (ab6671; Abcam), and donkey anti-
rabbit IgG H&L (Alexa Fluor 488; ab150073; Abcam). Cell nuclei
were stained with Hoechst Stain solution (H6024; SigmaeAldrich).
2.4. Flow cytometry
Macrophages in kidney were labeled and identiﬁed by ﬂow
cytometry. Brieﬂy, kidney was harvested and minced by scissors
and strainer. Acquired tissues were then fully digested using
collagenase D (0.05%; SigmaeAldrich). After ﬁltering impurities,
cells were counted and stained with allophycocyanin (APC)-CD11b
(17-0112; eBioscience, San Diego, CA, USA) at 4C for 30 min. Then
they were ﬁxed and permeabilized using Intracellular Fixation &
Permeabilization Buffer (plus Brefeldin A) kit (88-8823; eBio-
science) following manufacturer’s protocols. After that, cells were
stainedwith Alexa Fluor 488-NOS2 (iNOS; 53-5920; eBioscience) at
4C for 30min. All staining procedures were carried out in the dark.
Flow cytometry analysis was performed by using a FACSCalibur
ﬂow cytometer (BD Immunocytometry Systems, San Jose, CA, USA).
2.5. Macrophage culture and polarization
Bone marrow stem cells were acquired from mice femur and
tibia, maintained in Dulbecco’s modiﬁed Eagle medium (Invitrogen,
Carlsbad, CA, USA) supplemented with 10% fetal bovine serum,
2mM L-glutamine, 100 IU/mL penicillin, and 100 mg/mL strepto-
mycin sulfate and stimulated by macrophage colony stimulating
factor (10 ng/mL; PeproTech, Rocky Hill, NJ, USA) for 7 days. Mac-
rophages were collected and identiﬁed by ﬂow cytometry. M1
macrophage polarization was performed by adding lipopolysac-
charide (LPS; 100 ng/mL; SigmaeAldrich) plus interferon (IFN)-g
(50 ng/mL; PeproTech) for 24 h. GSRd concentration at 10 mg/mL,
20 mg/mL, 50 mg/mL, and 100 mg/mL and vehicle were added in the
culture mediumwhen polarized, a dose selected based on previous
investigations [3,15].
Fig. 1. Ginsenoside Rd signiﬁcantly reduces renal ischemia/reperfusion injury (IRI)-induced increase in (A) serum creatinine (Scr) and (B) blood urea nitrogen (BUN). The levels of
Scr and BUN in the surgery group compared to sham group were markedly high on Day 1 and Day 3. Group IRIþ50, IRIþ100 signiﬁcantly reduced Scr and BUN level on Day 3
compared to the sham group, while group IRIþvehicle and IRIþ10 did not display differences. IRIþ10: administration of 10 mg/kg ginsenoside Rd combined with renal IRI surgery.
Other groups ibid. (n ¼ 8e10 mice/group, values represent mean  standard deviation in the histograms. *p < 0.05 vs. vehicle.)
J Ginseng Res 2016;40:196e2021982.6. Real-time polymerase chain reaction
Macrophage total RNA was extracted using TRIzol reagent
(Invitrogen) according to themanufacturer’s instructions. cDNAwas
prepared with reverse transcription (RT) system (Takara, Dalian,
China). Quantitative real-time polymerase chain reaction (PCR) was
performed in triplicates using SYBR Premix EX Taq kit (Takara,
Dalian, China) and the ABI PRISM 7500 Real-Time PCR System, with
b-actin as an internal control. The following primers were used:
b-actin (forward: CATCCGTAAAGACCTCTATGCCAAC; reverse: ATG-
GAGCCACCGATCCACA); IL-12b (forward: GCTCGCAGCAAAG-
CAAGGTAA; reverse: CCATGAGTGGAGACACCAGCA); iNOS (forward:
CAAGCACATTTGGGAATGGAGA; reverse: CAGAACTGAGGGTA-
CATGCTGGAG); TNF-a (forward: TATGGCCCAGACCCTCACA;
reverse: GGAGTAGACAAGGTACAACCCATC).
2.7. Statistical analysis
Data were analyzed with GraphPad Prism software version 5.0
(GraphPad Software, San Diego, CA). Results are expressed as the
mean  SD. Differences between groups were assessed using one-
way ANOVA followed by Bonferroni posthoc test. A value of p< 0.05
was considered statistically signiﬁcant.
3. Results
3.1. GSRd alleviates mouse acute renal ischemia/reperfusion injury
All animals in the study showed that GSRd has no effects on body
temperature, blood pressure, or renal function in the absence ofFig. 2. Ginsenoside Rd (GSRd) alleviates renal tissue injury caused by ischemia/reperfusion
caused severe renal tissue damage compared to the sham group. Leukocyte inﬁltration and t
morphology started to improve from a GSRd concentration of 20 mg/kg. Tubular cell swellin
(B) Histology score assessed by two senior pathologists showed the improvement of tissue in
mice for each group, values represent mean  standard deviation in the histograms, ***p <renal IRI.GSRd-pretreatedmice received surgeryandweresacriﬁced
on Days 1, 3, 5, and 7, as were the sham and vehicle groups. Mice
kidneyand peripheral bloodwere acquired. Blood Scr andBUNwere
tested for all groups. The content became very high in the ﬁrst day
after surgery and gradually decreased as the time passed. GSRd
showedprotective role onDay1with relativelyhighdose (50mg/kg,
100mg/kg). Group IRIþ50 had a signiﬁcant effect on reducing blood
Scr and BUN to nearly the baseline level on Day 3. However, group
IRIþ100 did not show further protective function than group IRIþ50
as expected, which might indicate a dose-dependent relationship
between GSRd concentration and therapeutic effect (Fig. 1).
Hematoxylineeosin staining of group IRIþ50 on Day 3 also
showed the protective role of GSRd on tissue damage. Tubular cell
swelling and leukocyte inﬁltration decreased with incremental
concentration (Fig. 2A). Tissue damage could be observed on group
IRIþvehicle and IRIþ10, whereas it began to lighten gradually in
groups IRIþ20, IRIþ50, and IRIþ100. Histological scores assessed by
two senior pathologists showed therapeutic effect of GSRd on renal
IRI (Fig. 2B).
3.2. GSRd reduces M1 macrophages of renal ischemia tissue in situ
Since M1macrophages played essential role in renal IRI induced
inﬂammation, their phenotype and function in the case of GSRd
treatment will be our concern. To investigate this, mice kidneys
were immediately acquired after sacriﬁce for ﬂow cytometry
analysis and immunoﬂuorescence assay. Ratio of CD11bþ iNOSþ
macrophages was signiﬁcantly higher in IRI group compared with
sham surgery mice (Fig. 3A). These macrophages were regarded as
M1 phenotype, which exacerbates inﬂammation and tissue. (A) Hematoxylineeosin (H&E) staining showed that ischemia/reperfusion injury (IRI)
issue structure damage were mainly appeared on group IRIþvehicle and IRIþ10. Tissue
g and inﬂammatory cell inﬁltration signiﬁcantly reduced on group IRIþ50 and IRIþ100.
jury of the group receiving GSRd treatment. (Eight randomly-selected ﬁelds/slice, n ¼ 6
0.0001 vs. vehicle.)
Fig. 3. Administration of ginsenoside Rd reduces M1 macrophages inﬁltration ratio in model rat kidney. Complete kidney cells were acquired for ﬂow cytometry analysis. (A) The
ratio of CD11b and iNOS labeled M1 macrophages increased in group IRIþvehicle and reduced signiﬁcantly in group IRIþ20, IRIþ50 and IRIþ100; (B) Histogram statistics of whole
applied mice. (n ¼ 8e10/ group, values represent mean  standard deviation in the histograms, *p < 0.05 vs. vehicle.)
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concentration resulted in reduction of iNOSþ macrophages ratio in
renal tissue (Fig. 3B). Immunoﬂuorescence staining of macrophages
in kidney indicated that quantity of macrophage increased after
performing renal IRI surgery. Moreover, these macrophages
expressed M1 phenotype marker iNOS, IL-12, or TNF-a at the same
time. As shown in Fig. 4, group IRIþ20 and IRIþ50 had less CD11bþ
iNOSþ macrophages than group IRIþvehicle. This change had a
dose-dependency in a certain density range. However, it could stillFig. 4. Ginsenoside Rd reduces M1 macrophage in situ inﬁltration in IRI tissue detected b
iNOSþ/tumor necrosis factor-aþ/interleukin-12þ macrophages, respectively. Blue ﬂuoresce
sponding percentage of M1 macrophage among all kidney cells. (Eight randomly selected ﬁ
*p < 0.05 vs vehicle.)be seen that some inﬂammatory marker negative macrophages
existed within renal tissue.
3.3. GSRd regulate M1 macrophages polarization status in vitro
Since GSRd could suppress renal IRI accompanied with macro-
phages phenotype alteration, we next investigated its direct func-
tion acting on macrophage in vitro. Bone marrow stem cells were
harvested from mouse bone marrow and differentiated andy immunoﬂuorescence staining. (AeC)Red and green ﬂuorescence indicates CD11bþ,
nce indicates total nuclei in renal tissue. Original magniﬁcation: 400. (DeF) Corre-
elds/slice, n ¼ 6 mice for each group, values represent mean  SD in the histograms,
Fig. 5. Ginsenoside Rd suppresses M1 macrophage secreted inﬂammatory cytokines in vitro. Twenty-four hours after adding lipopolysaccharide (LPS)/interferon (IFN)-g, expression
of (A) tumor necrosis factor (TNF)a, (B) interleukin (IL)-12, and (C) iNOS were detected by real-time polymerase chain reaction. (n ¼ 8/group; values represent mean  standard
deviation in the histograms, *p < 0.05 vs. vehicle, **p < 0.01 vs. vehicle.)
J Ginseng Res 2016;40:196e202200polarized to M1macrophages as previous described. Concentration
gradient GSRd were added in the culture medium at the time of
polarization. After that, M1 macrophages related inﬂammatory
cytokine or enzyme TNFa, IL-12, and iNOS were detected by real-
time PCR. After adding LPS/IFN-g, which were used to induce the
M1phenotype [16], expression of typical cytokineswas signiﬁcantly
enhanced. However, this enhancement was reduced with adminis-
tration of GSRd. As shown in Fig. 5, this reduction started slightlyat a
GSRd concentration of 10 mg/mL. The 50e100 mg/mL group showed
distinct suppressive function on inﬂammatory cytokine expression.Fig. 6. Ginsenoside Rd modulates M1 macrophages morphology in vitro. (A) Nonpolarized
(LPS) and interferon (IFN)-g stimulation (all rest images), macrophages presented pancake
ﬁcation: 100, y: 200; (B) Percentage of pancake-like macrophages in all cultured cells. (n
vehicle, **p < 0.01 vs. vehicle, ***p < 0.001 vs. vehicle.)3.4. GSRd modulate M1 macrophages morphology in vitro
Nonpolarized macrophages had various types of shape
including round, threadlike, and pancake-like. In our study, differ-
entiated macrophages showed multiple morphology without reg-
ular pattern. After 24 h LPS stimulation, M1 macrophages began to
show typical pancake-like shape. However, a proportion of these
macrophages became decreased when GSRd were added in the
medium. More round and threadlike cell appeared in groups
IRIþ20, IRIþ50, and IRIþ100 (Fig. 6).macrophages have various types of shape (Control, Controly). After lipopolysaccharide
-like shape (Vehicle, Vehicley). 10: 10 mg/mL GSRd, Other groups ibid. Original magni-
¼ 8/group, values represent mean  standard deviation in the histograms, *p < 0.05 vs.
K. Ren et al / Rd alleviates renal I/R injury 2014. Discussion
In this study, we planned to ﬁnd out the role that GSRd played
on renal IRI. In general, we have demonstrated protective effects of
GSRd and its regulatory function on polarized macrophages.
Administration of GSRd alleviated renal tissue damage, reduced
iNOSþ M1 macrophages inﬁltration within the injury area and
improved renal function. In vitro study indicated an obvious role of
GSRd on macrophage polarization status. GSRd at certain concen-
trations suppressed inﬂammatory cytokine secretion of M1 mac-
rophages and mediated cell morphology as well.
Many studies have marked the essential role of macrophages in
renal ischemia/reperfusion injury [11,18]. Macrophages depletion
studies have suggested their key function during initial inﬂam-
mation and subsequent remodeling/ﬁbrosis [19,20]. Exploration of
therapeutic methods based on macrophage intervention has
attracted much attention. For instance, chemokine and chemokine
receptors CCR2 and CX3CR1 were studied for inﬁltration of
inﬂamed monocyte/macrophage in renal IRI [21]. Toll-like
receptors-2 and -4, which are mainly expressed on macro-
phages, were closely related to CCR2 expression and macrophage
inﬁltration [22,23]. Other cytokines and growth factors related to
macrophage, such as TNF-a, transforming growth factor-b, gran-
ulocyte macrophage colony-stimulating factor were also investi-
gated for relieving tissue injury [24e26].
Ginseng is one of the most famous medical herbs around the
world. It has been used as medication for a long time. In previous
studies, GSRd exhibited remarkable pharmacological function on
multiple diseases. It has been found that GSRd relieves inﬂamma-
tory injury by suppression of inducible nitric oxide synthase and
cyclooxygenase-2 expression in rat transient focal cerebral
ischemia [2]. In this study, GSRd attenuated oxidative DNA and
protein damage, lipid peroxidation, and consumption of the
endogenous antioxidant system activities, showing a neuro-
protective activity. GSRD also attenuated myocardial IRI in rat by
improving cardiac function, reducing infarct size and myocardial
apoptosis. It could reduce cardiomyocytes intracellular reactive
oxygen species generation, and activate Akt/GSK-3b signaling
pathway for antiapoptotic effect [3]. However, what exact role GSRd
plays on renal IRI is still unclear. Since macrophages are essential
for initiating ﬁrst step inﬂammation and following step remodel-
ing/ﬁbrosis, we planned to test if GSRd could regulate macrophage
functions and whether it is associated with renal IRI development
tendency afterwards.
This study is the ﬁrst to demonstrate the renal protective role of
GSRd for IRI in kidney. In the ﬁrst a few days after IRI, blood Scr and
BUN level dropped along with administration of GSRd in groups
IRIþ20, IRIþ50, and IRIþ100. Histology conﬁrmed the improve-
ment directly by observing less inﬂammatory cell inﬁltration and
better tissue morphology. We next applied immunoﬂuorescence
staining together with ﬂow cytometry to analyze M1 macrophage
population changes. The results indicated GSRd might either
decreased M1 macrophage inﬁltration or reduced incidence of cell
polarization. In order to clarify the direct function of GSRd on
macrophages, we carried an in vitro study to add GSRd in M1
macrophage culture medium. Real-time PCR data indicated that
GSRd could reduce inﬂammatory cytokine secretion of polarized
macrophage. These cytokines are among the primary causes of the
ﬁrst wave of injury. Furthermore, it is worth mentioning that
numbers of M1 macrophages, which had the typical pancake-like
morphology, decreased along with GSRd administration. This
phenomenon was ﬁrst observed among GSRd research. Together
with the functional study towards shape of polarized macrophage
[17], our medication showed a conﬁrmed intervention of reducing
M1 macrophage numbers.Although our study manifested protective role of GSRd on renal
IRI via regulation of macrophages, it is also necessary to discuss
mechanisms of this regulating process. M1 macrophage can be
activated by several signaling pathways. In IFN-g induced signaling,
Janus kinase 1 and 2 adaptors could activate signal transducers and
activators of transcription (STAT) 1 and interferon regulatory fac-
tors (IRF), such as IRF-1 and IRF-8 [27]. Suppressors of cytokine
signaling 1 and 3 could act as feedback inhibitor of the Janus kinase/
STAT 1 signaling [28]. In LPS induced signaling, Toll-like receptor 4
activation induces MyD88 and Toll-interleukin 1 receptor domain
containing adaptor protein (MaL/Tirap) dependent pathways. This
pathway is controlled by nuclear factor k light chain enhancer of
activated B cells, activator protein 1, IRFs, STAT1, and early growth
response family members [27,29]. A recent in vitro study indicated
an anti-inﬂammatory effect of GSRd by inhibition of iNOS and COX-
2 via suppression of nuclear factor k light chain enhancer of acti-
vated B cells signaling in RAW264.7 macrophage cell line [14].
However, a deeper and further study of the mechanism in vivo is
still needed.
Taken together, our results provide evidence for the ﬁrst time
that GSRd performs a protective role in renal IRI by modulating M1
macrophage polarization. It reduced macrophages inﬁltration and
decreased their inﬂammatory cytokine secretion. These results
indicate that GSRd, a traditional herbal medicine, display the
therapeutic potential for alleviating acute renal ischemia/reperfu-
sion injury.
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